Guirong Bai, Xiaomin Xie, Huili Liu, Dan Qiang, Yanting He, Li Zhang, Xiaojuan Zhang
{"title":"补体C1q肿瘤坏死因子相关蛋白-1 (CTRP-1)水平与代谢综合征的关系","authors":"Guirong Bai, Xiaomin Xie, Huili Liu, Dan Qiang, Yanting He, Li Zhang, Xiaojuan Zhang","doi":"10.5603/EP.a2023.0032","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Complement C1q tumour necrosis factor-related protein (CTRP-1) is a member of the C1q protein superfamily that plays a role in metabolism. This retrospective study aimed to investigate associations between CTRP-1 and metabolic syndrome (MetS).</p><p><strong>Material and methods: </strong>This study screened subjects who had undergone regular health examinations at the Physical Examination Centre in the First People's Hospital of Yinchuan (the Second Affiliated Hospital of Ningxia Medical University) between November 2017 and September 2020. The total recruited population included 430 subjects who had undergone regular health examinations, excluding 112 subjects with high glycated haemoglobin (HbA1c ≥ 7). Finally, the data of 318 participants were further analysed. Non-diabetic subjects were divided into 2 groups: one with MetS and one without MetS (controls). Serum CTRP-1 concentrations were evaluated using an enzyme-linked immunosorbent assay.</p><p><strong>Results: </strong>A total of 318 subjects were included, among whom 176 were diagnosed with MetS (MetS group) and 142 were not (non-MetS controls). The MetS group had significantly lower CTRP-1 levels than non-MetS controls (128.51 [111.56-143.05] vs. 138.82 [122.83-154.33] ng/mL, p < 0.001). Correlation analysis showed that serum CTRP-1 levels correlated negatively with body mass index (r = -0.161, p = 0.004), waist circumference (r = -0.191, p = 0.001), systolic blood pressure (r = -0.198, p < 0.001), diastolic blood pressure (r = -0.145, p = 0.010), fasting blood glucose (FBG) (r = -0.562, p < 0.001), fasting insulin (FIns) (r = -0.424, p < 0.001), and homeostasis model assessment of insulin resistance (HOMA-IR) (r = -0.541, p < 0.001). Multiple linear regression models showed that CTRP-1 levels were associated with MetS (p < 0.01). The lipid profile area under the curve (AUC) was comparable to those for FBG and FIns, and it was significantly higher than the AUCs for demographic variables.</p><p><strong>Conclusions: </strong>The results of this study suggest that the serum CTRP-1 level is negatively associated with MetS. CTRP-1 is a potential metabolism-related protein and is likely to be associated with lipid profiles in MetS.</p>","PeriodicalId":11551,"journal":{"name":"Endokrynologia Polska","volume":"74 3","pages":"271-276"},"PeriodicalIF":2.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The association between complement C1q tumour necrosis factor-related protein-1 (CTRP-1) level and metabolic syndrome.\",\"authors\":\"Guirong Bai, Xiaomin Xie, Huili Liu, Dan Qiang, Yanting He, Li Zhang, Xiaojuan Zhang\",\"doi\":\"10.5603/EP.a2023.0032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Complement C1q tumour necrosis factor-related protein (CTRP-1) is a member of the C1q protein superfamily that plays a role in metabolism. This retrospective study aimed to investigate associations between CTRP-1 and metabolic syndrome (MetS).</p><p><strong>Material and methods: </strong>This study screened subjects who had undergone regular health examinations at the Physical Examination Centre in the First People's Hospital of Yinchuan (the Second Affiliated Hospital of Ningxia Medical University) between November 2017 and September 2020. The total recruited population included 430 subjects who had undergone regular health examinations, excluding 112 subjects with high glycated haemoglobin (HbA1c ≥ 7). Finally, the data of 318 participants were further analysed. Non-diabetic subjects were divided into 2 groups: one with MetS and one without MetS (controls). Serum CTRP-1 concentrations were evaluated using an enzyme-linked immunosorbent assay.</p><p><strong>Results: </strong>A total of 318 subjects were included, among whom 176 were diagnosed with MetS (MetS group) and 142 were not (non-MetS controls). The MetS group had significantly lower CTRP-1 levels than non-MetS controls (128.51 [111.56-143.05] vs. 138.82 [122.83-154.33] ng/mL, p < 0.001). Correlation analysis showed that serum CTRP-1 levels correlated negatively with body mass index (r = -0.161, p = 0.004), waist circumference (r = -0.191, p = 0.001), systolic blood pressure (r = -0.198, p < 0.001), diastolic blood pressure (r = -0.145, p = 0.010), fasting blood glucose (FBG) (r = -0.562, p < 0.001), fasting insulin (FIns) (r = -0.424, p < 0.001), and homeostasis model assessment of insulin resistance (HOMA-IR) (r = -0.541, p < 0.001). Multiple linear regression models showed that CTRP-1 levels were associated with MetS (p < 0.01). The lipid profile area under the curve (AUC) was comparable to those for FBG and FIns, and it was significantly higher than the AUCs for demographic variables.</p><p><strong>Conclusions: </strong>The results of this study suggest that the serum CTRP-1 level is negatively associated with MetS. CTRP-1 is a potential metabolism-related protein and is likely to be associated with lipid profiles in MetS.</p>\",\"PeriodicalId\":11551,\"journal\":{\"name\":\"Endokrynologia Polska\",\"volume\":\"74 3\",\"pages\":\"271-276\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endokrynologia Polska\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5603/EP.a2023.0032\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endokrynologia Polska","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5603/EP.a2023.0032","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
简介:补体C1q肿瘤坏死因子相关蛋白(ctp -1)是C1q蛋白超家族成员,参与代谢。本回顾性研究旨在探讨CTRP-1与代谢综合征(MetS)之间的关系。材料与方法:本研究筛选于2017年11月至2020年9月在银川市第一人民医院(宁夏医科大学第二附属医院)体检中心定期进行健康检查的受试者。总招募人群包括430名接受定期健康检查的受试者,排除了112名糖化血红蛋白(HbA1c≥7)较高的受试者。最后,对318名受试者的数据进行进一步分析。非糖尿病受试者分为两组:一组有MetS,一组无MetS(对照组)。采用酶联免疫吸附法测定血清CTRP-1浓度。结果:共纳入318名受试者,其中176名被诊断为MetS (MetS组),142名未被诊断为MetS(非MetS对照组)。MetS组CTRP-1水平显著低于非MetS组(128.51 [111.56-143.05]vs. 138.82 [122.83-154.33] ng/mL, p < 0.001)。相关分析显示,血清CTRP-1水平与体重指数(r = -0.161, p = 0.004)、腰围(r = -0.191, p = 0.001)、收缩压(r = -0.198, p < 0.001)、舒张压(r = -0.145, p = 0.010)、空腹血糖(FBG) (r = -0.562, p < 0.001)、空腹胰岛素(FIns) (r = -0.424, p < 0.001)、胰岛素抵抗稳态模型评估(HOMA-IR) (r = -0.541, p < 0.001)呈负相关。多元线性回归模型显示CTRP-1水平与MetS相关(p < 0.01)。血脂曲线下面积(AUC)与FBG和FIns相当,明显高于人口统计学变量的AUC。结论:本研究结果提示血清CTRP-1水平与MetS呈负相关。CTRP-1是一种潜在的代谢相关蛋白,可能与MetS中的脂质谱有关。
The association between complement C1q tumour necrosis factor-related protein-1 (CTRP-1) level and metabolic syndrome.
Introduction: Complement C1q tumour necrosis factor-related protein (CTRP-1) is a member of the C1q protein superfamily that plays a role in metabolism. This retrospective study aimed to investigate associations between CTRP-1 and metabolic syndrome (MetS).
Material and methods: This study screened subjects who had undergone regular health examinations at the Physical Examination Centre in the First People's Hospital of Yinchuan (the Second Affiliated Hospital of Ningxia Medical University) between November 2017 and September 2020. The total recruited population included 430 subjects who had undergone regular health examinations, excluding 112 subjects with high glycated haemoglobin (HbA1c ≥ 7). Finally, the data of 318 participants were further analysed. Non-diabetic subjects were divided into 2 groups: one with MetS and one without MetS (controls). Serum CTRP-1 concentrations were evaluated using an enzyme-linked immunosorbent assay.
Results: A total of 318 subjects were included, among whom 176 were diagnosed with MetS (MetS group) and 142 were not (non-MetS controls). The MetS group had significantly lower CTRP-1 levels than non-MetS controls (128.51 [111.56-143.05] vs. 138.82 [122.83-154.33] ng/mL, p < 0.001). Correlation analysis showed that serum CTRP-1 levels correlated negatively with body mass index (r = -0.161, p = 0.004), waist circumference (r = -0.191, p = 0.001), systolic blood pressure (r = -0.198, p < 0.001), diastolic blood pressure (r = -0.145, p = 0.010), fasting blood glucose (FBG) (r = -0.562, p < 0.001), fasting insulin (FIns) (r = -0.424, p < 0.001), and homeostasis model assessment of insulin resistance (HOMA-IR) (r = -0.541, p < 0.001). Multiple linear regression models showed that CTRP-1 levels were associated with MetS (p < 0.01). The lipid profile area under the curve (AUC) was comparable to those for FBG and FIns, and it was significantly higher than the AUCs for demographic variables.
Conclusions: The results of this study suggest that the serum CTRP-1 level is negatively associated with MetS. CTRP-1 is a potential metabolism-related protein and is likely to be associated with lipid profiles in MetS.
期刊介绍:
"Endokrynologia Polska" publishes papers in English on all aspects of clinical and experimental endocrinology. The following types of papers may be submitted for publication: original articles, reviews, case reports, postgraduate education, letters to the Editor (Readers’ Forum) and announcements of scientific meetings, conferences and congresses.